These exosomes effectively blocked Tau protein phosphorylation through the AKT/GSK‐3β signaling pathway, preventing neuronal death in both in vitro and in vivo models, which ultimately contributed to alleviating AD‐related symptoms [173]. Here, AKT1 is linked to Alzheimer disease.